4//SEC Filing
Mostafa Adam S. 4
Accession 0001628280-22-023323
CIK 0001501697other
Filed
Aug 18, 8:00 PM ET
Accepted
Aug 19, 1:04 PM ET
Size
5.3 KB
Accession
0001628280-22-023323
Insider Transaction Report
Form 4
Mostafa Adam S.
Chief Financial Officer
Transactions
- Sale
Common Stock
2022-08-17−10,834→ 173,917 total
Footnotes (3)
- [F1]The reported transaction was effected pursuant to a Rule 10b5-1 trading plan.
- [F2]The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $1.150 to $1.215, inclusive. The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F3]Represents unvested restricted stock units.
Documents
Issuer
X4 Pharmaceuticals, Inc
CIK 0001501697
Entity typeother
Related Parties
1- filerCIK 0001738081
Filing Metadata
- Form type
- 4
- Filed
- Aug 18, 8:00 PM ET
- Accepted
- Aug 19, 1:04 PM ET
- Size
- 5.3 KB